Related categories
Siblings:
119 found
Search inside:
(import / add options)   Sort by:
1 — 50 / 119
  1. Melinda Abelman, P. Pearl O'Rourke & Kai C. Sonntag (2012). Part-Human Animal Research: The Imperative to Move Beyond a Philosophical Debate. American Journal of Bioethics 12 (9):26-28.
    The American Journal of Bioethics, Volume 12, Issue 9, Page 26-28, September 2012.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  2. Roger Achille, Christine Perakslis & Katina Michael (2012). Ethical Issues to Consider for Microchip Implants in Humans. Ethics in Biology, Engineering and Medicine 3 (1-3):75-86.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  3. Mike Adcock (2004). The Relationship Between IP and Biotechnology. Global Bioethics 17 (1):25-29.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  4. Mike Adcock & Julian Kinderlerer (2004). The Detail of Law Relating to Modern Biotechnology. Global Bioethics 17 (1):113-117.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  5. Ademola A. Adenle (2014). Stakeholders' Perceptions of GM Technology in West Africa: Assessing the Responses of Policymakers and Scientists in Ghana and Nigeria. [REVIEW] Journal of Agricultural and Environmental Ethics 27 (2):241-263.
    The perception of two key stakeholders such as policymakers and scientists on genetic modification (GM) technology was examined in Ghana and Nigeria using semi-structured interviews. A total sample of 20 policymakers (16 at ministries and 4 at parliament/cabinet) and 58 scientists (43 at research institutes and 15 at universities) participated at the interviews. This study revealed respondents perspectives on potential benefits and risks of GM technology, status and development of biosafety regulatory frameworks, role of science and technology innovation in agricultural (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  6. New Zealand Advisory Committee on Assisted Reproductive Technology (2010). Committee Advice on Embryo Splitting. Jahrbuch für Wissenschaft Und Ethik 14:313-318.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  7. Emmanuel Agius (2013). Biotechnology and Human Dignity. Human Reproduction and Genetic Ethics 17 (2):155 - 184.
    The precise meaning of “human dignity” is increasingly being questioned in ethics and law. Is human dignity an adequate guide to policymaking in today’s biotechnological era? This article is an attempt to answer this thorny issue. The emergence of the concept of human dignity as a key point of reference for the regulation of modern science and technology in the European Union is evaluated. The main contribution of this article is to prove that in EU Directives and Recommendations, human dignity (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  8. Jaime Ahlberg & Harry Brighouse (2011). An Argument Against Cloning. Canadian Journal of Philosophy 40 (4):539-566.
    It is technically possible to clone a human being. The result of the procedure would be a human being in its own right. Given the current level of cloning technology concerning other animals there is every reason to believe that early human clones will have shorter-than-average life-spans, and will be unusually prone to disease. In addition, they would be unusually at risk of genetic defects, though they would still, probably, have lives worth living. But with experimentation and experience, seriously unequal (...)
    Remove from this list | Direct download (8 more)  
     
    My bibliography  
     
    Export citation  
  9. Fritz Allhoff, Patrick Lin & Jesse Steinberg (2011). Ethics of Human Enhancement: An Executive Summary. [REVIEW] Science and Engineering Ethics 17 (2):201-212.
    Remove from this list | Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  10. Joseph S. Alper & Jon Beckwith (1998). Distinguishing Genetic From Nongenetic Medical Tests: Some Implications for Antidiscrimination Legislation. Science and Engineering Ethics 4 (2):141-150.
    Genetic discrimination is becoming an increasingly important problem in the United States. Information acquired from genetic tests has been used by insurance companies to reject applications for insurance policies and to refuse payment for the treatment of illnesses. Numerous states and the United States Congress have passed or are considering passage of laws that would forbid such use of genetic information by health insurance companies. Here we argue that much of this legislation is severely flawed because of the difficulty in (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  11. Ian Angell (2008). As I See It: Enclosing Identity. [REVIEW] Identity in the Information Society 1 (1):23-37.
    This article claims that an ‘enclosure of the commons’ is underway, which reaches far beyond intellectual property, to a point where, through profiling, ‘identity’ has itself become enclosed property that can be owned by another. With a detour through the natures of both money and innovation, this paper looks at the imperative driving ‘intellectual property rights.’ By introducing the notion of biopiracy, it shows how ‘invasion of privacy’ is justified, and ends with “a world of rapacious, state-aided ‘privatization’” of enclosed (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  12. Jonny Anomaly (2012). Review of Allen Buchanan, Beyond Humanity? The Ethics of Biomedical Enhancement. [REVIEW] Bioethics 26 (7):391-392.
    Remove from this list | Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  13. D. Archard (forthcoming). Carole Ulanowsky, Ed., The Family in the Age of Biotechnology. Radical Philosophy.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  14. David Archard (1996). The Family in the Age of Biotechnology. [REVIEW] Radical Philosophy 77.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  15. Richard Arneson, Is Moral Theory Perplexed by New Genetic Technology?
    Richard J. Arneson From Choice to Chance: Genes and the Just Society1 intelligently addresses difficult issues at the intersection of medical ethics and the theory of justice. The authors, Dan Brock, Allen Buchanan, Norman Daniels, and Daniel Wikler, repeatedly emphasize their opinion that advances in genetic technology force upon us entirely new ethical questions which previous moral theories lack the resources to resolve.2 The claims that new scientific discoveries render previous moral theories obsolete should be regarded with suspicion. The reader’s (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  16. Andrew Askland (2003). Patenting Genes. International Journal of Applied Philosophy 17 (2):267-275.
    Patents have been issued in the United States for genes and gene sequences since 1980. Patent protection has provided incentives to aggressively probe the genome of humans and non-humans alike in search of profitable applications. Yet it is not clear that patent protection should have been afforded to genes and gene sequences and it is increasingly clear that patent protection, as currently formulated, is not an appropriate means to realize the full benefits of genetic research. As we stand on the (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  17. Christoph Asmuth, Benedetta Bisol & Patrick Grüneberg (2010). Modelle und Grenzen der Leistungssteigerung im Sport: Enhancement, Doping, Therapie aus philosophischer Sicht. Leipziger Sportwissenschaftliche Beiträge 51 (2):8-43.
    Enhancement is a basic principle of modern sport. Their increase of achievement is usually attributed to the sportsmen’s natural assessment, their health, their training methods and their employment. In contrast, increase in output by pharmacological means is outlawed. The modern medical techniques created a whole range, by which sportsmen are supported. Consequently, sometimes difficult decisions with concrete medications develop. It is not always clearly to be differentiated whether something is a pharmacological interference, which serves the therapy or leads however to (...)
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  18. Robin Attfield (2012). Synthetic Biology, Deontology and Synthetic Bioethics. Ethics, Policy and Environment 15 (1):29 - 32.
    Paul Thompson argues that current synthetic biology amounts to synthetic genomics, comprising a ?platform? technology, and that Christopher Preston's deontological objections based on its supposed rejection of the historical process of evolution miscarry. This makes it surprising that Thompson's normative ethic consists in a deontological appeal to Kantian duties of imperfect obligation. Construed as obligations subject to choice, such constraints risk being excessively malleable where the ethical objections to deployment of this technology concern land rights and/or exploitation. Thompson's advocacy of (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  19. Carol Auer (2009). A Century of Crop Improvement: From Vavilov to Biotechnology. BioScience 59 (5):436-438.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  20. Beth Baker (1996). Building a Better Oyster Scientists Use the Biotechnology Tool Chest to Produce a Steady Supply of a Favorite Seafood. BioScience 46 (4):240-244.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  21. Wendy Baldwin (2002). Conflict of Interest and its Significance in Science and Medicine Warsaw, Poland, 5–6 April, 2002. Science and Engineering Ethics 8 (3):469-475.
    This article summarizes the April 5–6, 2002 conference on Conflict of Interest and Its Significance in Science and Medicine. Several themes are identified and addressed, including the globalization of science, the widespread presence of conflicts, the increased interest and involvement in conflict of interest by a number of organizations, the difference between academic research and research conducted by industry, and the tension between science and medicine. At the heart of the matter lies objectivity in research and the need for transparency (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  22. Rosangela Barcaro (2014). L'arte della vita: biotecnologie e bioetica [Bioart, biotechnology and bioethics]. Aisthema. International Journal, ISSN 2284-3515 1 (2):23-45.
    Bioart is an artistic experience that relates art, science and biotechnology by examining the concepts of life, evolution and nature from a new point of view. The revolutionary idea at the basis of this experience is the use of living organic matter as an expressive medium, handled with techniques which are made possible by the latest scientific and technological breakthroughs. Bioart aims at allowing a broader public the understanding and discussion of the problems related to activities that shape the relationship (...)
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  23. Lauren Bartlett, P. Aarne Vesilind & P. Aarne Vesilind (1998). Expediency and Human Health: The Regulation of Environmental Chromium. Science and Engineering Ethics 4 (2):191-201.
    The complexity of chromium chemistry makes it an ideal example of how the Principle of Expediency, first articulated by sanitary pioneer Earle Phelps, can be used in a standard setting. Expediency, defined by Phelps as “the attempt to reduce the numerical measure of probable harm, or the logical measure of existing hazard, to the lowest level that is practicable and feasible within the limitations of financial resources and engineering skill”, can take on negative connotations unless subject to ethical guidance. In (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  24. John Basl (2010). State Neutrality and the Ethics of Human Enhancement Technologies. AJOB 1 (2):41-48.
    Robust technological enhancement of core cognitive capacities is now a realistic possibility. From the perspective of neutralism, the view that justifications for public policy should be neutral between reasonable conceptions of the good, only members of a subset of the ethical concerns serve as legitimate justifications for public policy regarding robust technological enhancement. This paper provides a framework for the legitimate use of ethical concerns in justifying public policy decisions regarding these enhancement technologies by evaluating the ethical concerns that arise (...)
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  25. Fiorella Battaglia & Nikil Mukerji (forthcoming). Technikethik. In Julian Nida-Rümelin, Irina Spiegel & Markus Tiedemann (eds.), Handbuch Philosophie und Ethik - Band 2: Disziplinen und Themen. UTB
  26. Fiorella Battaglia, Nikil Mukerji & Julian Nida-Rümelin (2014). Science, Technology, and Responsibility. In Fiorella Battaglia, Nikil Mukerji & Julian Nida-Rümelin (eds.), Rethinking Responsibility in Science and Technology. Pisa University Press 7-11.
    The empirical circumstances in which human beings ascribe responsibility to one another are subject to change. Science and technology play a great part in this transformation process. Therefore, it is important for us to rethink the idea, the role and the normative standards behind responsibility in a world that is constantly changing under the influence of scientific and technological progress. This volume is a contribution to that joint societal effort.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  27. Christoph Baumgartner (2006). Exclusion by Inclusion? On Difficulties with Regard to an Effective Ethical Assessment of Patenting in the Field of Agricultural Bio-Technology. Journal of Agricultural and Environmental Ethics 19 (6):521-539.
    In order to take ethical considerations of patenting biological material into account, the so-called “ordre public or morality clause” was implemented as Article 6 in the EC directive on the legal protection of biotechnological inventions, 98/44/EC. At first glance, this seems to provide a significant advantage to the European patent system with respect to ethics. The thesis of this paper argues that the ordre public or morality clause does not provide sufficient protection against ethically problematic uses of the patent system (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  28. James B. Beal (1974). 13 The New Biotechnology James B. Beal. In John Warren White (ed.), Frontiers of Consciousness: The Meeting Ground Between Inner and Outer Reality. Julian Press 213.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  29. Timothy M. Beardsley (2011). How to Get Real About Biotechnology. BioScience 61 (9):651-651.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  30. Tom L. Beauchamp (1987). Medical Ethics in the Age of Technology. In Hans Mark & W. Lawson Taitte (eds.), Traditional Moral Values in the Age of Technology. Distributed by the University of Texas Press
  31. Volkert Beekman & Frans W. A. Brom (2007). Ethical Tools to Support Systematic Public Deliberations About the Ethical Aspects of Agricultural Biotechnologies. Journal of Agricultural and Environmental Ethics 20 (1):3-12.
    This special issue of the Journal of Agricultural and Environmental Ethics presents so-called ethical tools that are developed to support systematic public deliberations about the ethical aspects of agricultural biotechnologies. This paper firstly clarifies the intended connotations of the term “ethical tools” and argues that such tools can support liberal democracies to cope with the issues that are raised by the application of genetic modification and other modern biotechnologies in agriculture and food production. The paper secondly characterizes the societal discussion (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  32. Steven Best (2006). Genetic Science, Animal Exploitation, and the Challenge for Democracy. AI and Society 20 (1):6-21.
    As the debates over cloning and stem cell research indicate, issues raised by biotechnology combine research into the genetic sciences, perspectives and contexts articulated by the social sciences, and the ethical and anthropological concerns of philosophy. Consequently, I argue that intervening in the debates over biotechnology requires supra-disciplinary critical philosophy and social theory to illuminate the problems and their stakes. In addition, debates over cloning and stem cell research raise exceptionally important challenges to bioethics and a democratic politics of communication.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  33. Frederick R. Bieber (2006). Turning Base Hits Into Earned Runs: Improving the Effectiveness of Forensic DNA Data Bank Programs. Journal of Law, Medicine & Ethics 34 (2):222-233.
    This manuscript provides an overview of forensic DNA data banks and their use, with some focus on existing programs established in the U.S., Canada, and the U.K. The intent is to provide a constructive analysis of both strengths and weaknesses in performance, and especially to suggest directions for improvement. Implementation of these suggestions will be crucial to allow DNA data banks to be most effective in advancing societal goals of enhancing public safety and collective security.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  34. Public Acceptability of Agricultural Biotechnology (1995). Biotechnology: An Agricultural Revolution. In T. B. Mepham, G. A. Tucker & J. Wiseman (eds.), Issues in Agricultural Bioethics. Nottingham University Press
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  35. Nick Bostrom (forthcoming). Smart Policy: Cognitive Enhancement and the Public Interest. In Julian Savulescu, Ruud ter Muelen & Guy Kahane (eds.), Enhancing Human Capabilities. Wiley-Blackwell
    Cognitive enhancement may be defined as the amplification or extension of core capacities of the mind through improvement or augmentation of internal or external information processing systems. Cognition refers to the processes an organism uses to organize information. These include acquiring information (perception), selecting (attention), representing (understanding) and retaining (memory) information, and using it to guide behavior (reasoning and coordination of motor outputs). Interventions to improve cognitive function may be directed at any of these core faculties.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  36. Frans W. A. Brom (2000). The Good Life of Creatures with Dignity Some Comments on the Swiss Expert Opinion. Journal of Agricultural and Environmental Ethics 13 (1):53-63.
    The notion of Dignity of Creatures has been voted into the Swiss Federal Constitution by a plebiscite. Philipp Balzer, Klaus-Peter Rippe, and Peter Schaber have given an expert opinion for the Swiss government to clarify the notion of Dignity of Creatures. According to them, by voting this notion into the Swiss constitution, the Swiss have chosen for a limited biocentric approach towards biotechnology. In such an approach genetic engineering of non-human beings is only allowed insofar that their own good is (...)
    Remove from this list | Direct download (8 more)  
     
    My bibliography  
     
    Export citation  
  37. Jeffrey Burkhardt (2001). Agricultural Biotechnology and the Future Benefits Argument. Journal of Agricultural and Environmental Ethics 14 (2):135-145.
    In the face of criticisms about the current generationof agricultural biotechnology products, some proponents ofagricultural biotechnology offer a ``future benefitsargument''''(FBA), which is a utilitarian ethical argument thatattempts to justify continued R&D. This paper analyzes severallogical implications of the FBA. Among these are that acceptanceof the FBA implies (1) acceptance of a precautionary approach torisk, (2) the need for a more proportional and equitabledistribution of the benefits of agricultural biotechnology, andmost important, (3) the need to reorient and restructurebiotechnology R&D institutions (and (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  38. Jeanne L. Burton & Brian W. McBride (1989). Recombinant Bovine Somatotropin (rbST): Is There a Limit for Biotechnology in Applied Animal Agriculture? Journal of Agricultural and Environmental Ethics 2 (2):129-159.
    The intent of this article is to outline, integrate, and interpret relevant scientific, economic, and social issues of rbST technology that have contributed to the acceptance dilemma for this product. The public is divided into social groups, each with its own set of criteria on which they base rbSTs acceptability. Criteria for the scientific community may best be described as physiological. However, for consumers, criteria may be more practical, or procedural, including human health, animal welfare, environmental concerns, and overproduction. Because (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  39. Martin Calkins (2002). How Casuistry and Virtue Ethics Might Break the Ideological Stalemate Troubling Agricultural Biotechnology. Business Ethics Quarterly 12 (3):305-330.
    Abstract: This article begins by showing how recent controversies over the widespread promotion of artificially gene-altered foods are rooted in opposing ethical and ideological worldviews. It then explains how these contrasting worldviews have led to a practical, ethical, and ideological standoff and, finally, suggests the combined use of casuistry and virtue ethics as a way for both sides to move ahead on this pressing issue.
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  40. Margaret A. Clark (1999). This Little Piggy Went to Market: The Xenotransplantation and Xenozoonose Debate. Journal of Law, Medicine & Ethics 27 (2):137-152.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  41. Benjamin M. Cole & Preeta M. Banerjee (2013). Morally Contentious Technology-Field Intersections: The Case of Biotechnology in the United States. [REVIEW] Journal of Business Ethics 115 (3):555-574.
    Technologies can be not only contentious—overthrowing existing ways of doing things—but also morally contentious—forcing deep reflection on personal values and societal norms. This article investigates that what may impede the acceptance of a technology and/or the development of the field that supports or exploits it, the lines between which often become blurred in the face of morally contentious content. Using a unique dataset with historically important timing—the United States Biotechnology Study fielded just 9 months after the public announcement of the (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  42. Benjamin L. Curtis (2012). Moral Enhancement as Rehabilitation? American Journal of Bioethics (Neuroscience) 3:23-24.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  43. Anthony Mark Cutter & Bert Gordijn (2007). Questions of Human Enhancement: An Editorial. Studies in Ethics, Law, and Technology 1 (1).
    Introducing a special issue of a journal is a difficult, but pleasurable task for any editor. One must chose what to say about the themes of the issue, and how to introduce the papers presented. However, this task becomes still more complex when the special issue in question forms the inaugural issue of a new journal. This is the case here as we find ourselves introducing "Questions in Human Enhancement" as the inaugural issue of Studies in Ethics, Law and Technology. (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  44. Rafael Dal-Re, Xavier Carné & Diego Gracia (eds.) (2013). Luces y sombras en la investigación clínica. Triacastela, Fundació Víctor Grífols I Lucas.
    La investigación clínica, entendida como la búsqueda de soluciones para los problemas que acechan a la salud es, por su objetivo, una de las actividades de mayor trascendencia para el ser humano. Esta obra colectiva, como su propio título indica, explora no solo lo mucho que de positivo (las luces) tiene la investigación clínica, cómo se realiza, qué problemas encuentra y qué soluciones se plantean, sino también algunos aspectos negativos (las sombras) que la comunidad científica ha sido, hasta la fecha, (...)
    Remove from this list |
    Translate to English
    | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  45. Aubrey D. N. J. de Grey (2007). Life Span Extension Research and Public Debate: Societal Considerations. Studies in Ethics, Law, and Technology 1 (1).
    The pace of a given strand of scientific research, whether purely curiosity-driven or motivated by a particular technological goal, is strongly influenced by public attitudes towards its value. In the case of research directed to the radical postponement of aging and the consequent extension of healthy and total lifespans, public opinion is entrenched in a "pro-aging trance" - a state of resolute irrationality. This arises from the entirely rational attitude to a grisly, inevitable and relatively far-off fate: putting it out (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  46. Adalberto de Hoyos, Rodrigo Nava-Diosdado, Jorge Mendez, Sergio Ricco, Ana Serrano, Carmen Flores Cisneros, Carlos Macías-Ojeda, Héctor Cisneros, David Bialostozky, Nelly Altamirano-Bustamante & Myriam Altamirano-Bustamante (2013). Cardiovascular Medicine at Face Value: A Qualitative Pilot Study on Clinical Axiology. Philosophy, Ethics, and Humanities in Medicine 8 (1):3.
    Cardiology is characterized by its state-of-the-art biomedical technology and the predominance of Evidence-Based Medicine. This predominance makes it difficult for healthcare professionals to deal with the ethical dilemmas that emerge in this subspecialty. This paper is a first endeavor to empirically investigate the axiological foundations of the healthcare professionals in a cardiology hospital. Our pilot study selected, as the target population, cardiology personnel not only because of their difficult ethical deliberations but also because of the stringent conditions in which they (...)
    Remove from this list | Direct download (11 more)  
     
    My bibliography  
     
    Export citation  
  47. Annette Dufner (2013). Potentiality Arguments and the Definition of “Human Organism”. American Journal of Bioethics 13 (1):33-34.
    Bettina Schöne-Seifert and Marco Stier present a host of detailed and intriguing arguments to the effect that potentiality arguments have to be viewed as outdated due to developments in stem cell research, in particular the possibility of re-setting the development potential of differentiated cells, such as skin cells. However, their argument leaves them without an explanation of the intuitive difference between skin cells and human beings, which seems to be based on the assumption that a skin cell is merely part (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  48. Margaret L. Eaton (2004). Ethics and the Business of Bioscience. Stanford Business Books.
    Businesses that produce bioscience products—gene tests and therapies, pharmaceuticals, vaccines, and medical devices—are regularly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work. This groundbreaking book follows industry research, development, and marketing of medical and bioscience products across a variety of fields, (...)
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  49. Ron Epstein, Buddhism and Biotechnology.
    The topic of this panel is "Biotechnology: Boon or Bane for Spiritual Development." It has very often been said that we are on the threshold of the biotech century, and I am sure that all of you are very clearly aware that genetic engineering is going to totally reshape life on this planet in many ways: economically, politically, scientifically--particularly in terms of medicine, and also environmentally. Most important for all of us is what the relationship of this incredible technology will (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  50. N. G. Evans (2013). Great Expectations—Ethics, Avian Flu and the Value of Progress. Journal of Medical Ethics 39 (4):209-213.
    A recent controversy over the US National Science Advisory Board for Biosecurity's recommendation to censor two publications on genetically modified H5N1 avian influenza has generated concern over the threat to scientific freedom such censorship presents. In this paper, I argue that in the case of these studies, appeals to scientific freedom are not sufficient to motivate a rejection of censorship. I then use this conclusion to draw broader concerns about the ethics of dual-use research.
    Remove from this list | Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
1 — 50 / 119